These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31438566)

  • 41. Characterization of melt-quenched and milled amorphous solids of gatifloxacin.
    Hattori Y; Suzuki A; Otsuka M
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1851-6. PubMed ID: 27109418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repurposing Melt Degradation for the Evaluation of Mixed Amorphous-Crystalline Blends.
    Abdul-Jabbar S; Wong DW; Martin GP; Woodhead B; Royall PG
    AAPS PharmSciTech; 2021 Mar; 22(3):105. PubMed ID: 33718988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fundamentals of freeze-drying.
    Nail SL; Jiang S; Chongprasert S; Knopp SA
    Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of formulation and process factors on the crystal structure of freeze-dried Myo-inositol.
    Izutsu K; Yomota C; Okuda H; Kawanishi T; Yamaki T; Ohdate R; Yu Z; Yonemochi E; Terada K
    J Pharm Sci; 2014 Aug; 103(8):2347-55. PubMed ID: 24916801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stabilization of IgG1 in spray-dried powders for inhalation.
    Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W
    Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solids.
    Lechuga-Ballesteros D; Bakri A; Miller DP
    Pharm Res; 2003 Feb; 20(2):308-18. PubMed ID: 12636173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials.
    Corrigan DO; Healy AM; Corrigan OI
    Int J Pharm; 2003 Aug; 262(1-2):125-37. PubMed ID: 12927394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study.
    Penumetcha SS; Gutta LN; Dhanala H; Yamili S; Challa S; Rudraraju S; Rudraraju S; Rudraraju V
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1609-20. PubMed ID: 26925514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry.
    Otsuka M; Kato F; Matsuda Y
    AAPS PharmSciTech; 2002; 3(4):E30. PubMed ID: 12916924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
    Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
    Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physical stability of salmon calcitonin spray-dried powders for inhalation.
    Chan HK; Clark AR; Feeley JC; Kuo MC; Lehrman SR; Pikal-Cleland K; Miller DP; Vehring R; Lechuga-Ballesteros D
    J Pharm Sci; 2004 Mar; 93(3):792-804. PubMed ID: 14762916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystallization kinetics and glass-forming ability of rapidly crystallizing drugs studied by Fast Scanning Calorimetry.
    Lapuk SE; Mukhametzyanov TA; Schick C; Gerasimov AV
    Int J Pharm; 2021 Apr; 599():120427. PubMed ID: 33662469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spray drying of budesonide, formoterol fumarate and their composites--I. Physicochemical characterisation.
    Tajber L; Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2009 Feb; 367(1-2):79-85. PubMed ID: 18929631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stability of crystallised and spray-dried lysozyme.
    Elkordy AA; Forbes RT; Barry BW
    Int J Pharm; 2004 Jul; 278(2):209-19. PubMed ID: 15196626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Amorphization Methods on the Physicochemical Properties of Amorphous Lactulose.
    Ngono F; Willart JF; Cuello GJ; Jimenez-Ruiz M; Yelles CH; Affouard F
    Mol Pharm; 2020 Jan; 17(1):1-9. PubMed ID: 31647674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amorphous pharmaceutical solids: preparation, characterization and stabilization.
    Yu L
    Adv Drug Deliv Rev; 2001 May; 48(1):27-42. PubMed ID: 11325475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix.
    Vandenheuvel D; Meeus J; Lavigne R; Van den Mooter G
    Int J Pharm; 2014 Sep; 472(1-2):202-5. PubMed ID: 24950368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding the physical stability of freeze dried dosage forms from the glass transition temperature of the amorphous components.
    Fitzpatrick S; Saklatvala R
    J Pharm Sci; 2003 Dec; 92(12):2495-501. PubMed ID: 14603495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.